Basic Materials / Specialty ChemicalsBSE
$2098.00
+35.50 (+1.72%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-390.5M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$41.9B
P/E
58.8x
↑EV/EBITDA
37.2x
↑ROE
18.8%
↑Gross Margin
37.5%
↑Debt/Equity
0.25
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+24.3%
FCF CAGR
—
FCF margin
-5.5%
FCF / Net income
-0.56x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $7.11B · net income $701.4M · FCF $-390.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.11B | $7.11B | $5.57B | $3.74B | $3.71B |
| Net Income | $701.4M | $701.4M | $881.5M | $524.8M | $561.3M |
| EBITDA | $1.14B | $1.14B | $1.32B | $777.9M | $818.5M |
| EPS | 35.16 | 35.16 | 44.18 | 26.30 | 28.14 |
| Gross Margin | 37.5% | 37.5% | 45.2% | 38.5% | 36.4% |
| Operating Margin | 13.3% | 13.3% | 21.3% | 18.0% | 18.9% |
| Net Margin | 9.9% | 9.9% | 15.8% | 14.0% | 15.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.25 | 0.25 | 0.13 | — | — |
| Current Ratio | 1.77 | 1.77 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-390.5M | $-390.5M | $-641.9M | $-18.9M | $280.3M |
| Returns | |||||
| ROE | 18.8% | 18.8% | 28.3% | 22.8% | 30.5% |
| Valuation | |||||
| P/E | 58.80 | 58.80 | 31.62 | 39.50 | 20.53 |
| EV/EBITDA | 37.21 | 37.21 | 21.23 | 26.55 | 13.95 |
| P/B | 11.22 | 11.22 | 8.93 | 9.00 | 6.25 |
| Growth & Yield | |||||
| Revenue Growth | 27.7% | 27.7% | 49.1% | 0.8% | — |
| EPS Growth | -20.4% | -20.4% | 68.0% | -6.5% | — |
| Dividend Yield | 0.2% | 0.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
74.3%
EPS terminal req.
$186.16
Spread vs growth
-94.7%
5Y implied EPS CAGR
45.0%
EPS terminal req.
$225.26
Spread vs growth
-65.4%
10Y implied EPS CAGR
26.3%
EPS terminal req.
$362.78
Spread vs growth
-46.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+34.9%
Start / end P/E
35.3x → 59.7x
EPS bridge
44.18 → 35.16
Residual
-14.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.